Expanding the toolbox to combat a pandemic Editorial
| Author: | Prockop, S. E. |
| Title: | Expanding the toolbox to combat a pandemic |
| Abstract: | Understanding immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for optimizing treatment of COVID-19. In this issue of Blood, Keller and colleagues1 generated SARS-CoV-2–specific cytotoxic T lymphocytes (CTLs) from the blood of individuals recovered from infection. The rapid application of this good manufacturing practice (GMP)compliant system raises the possibility that banked third-party SARS-CoV-2 CTLs could be used for treatment. © 2020 American Society of Hematology. All rights reserved. |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | 25 |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-12-17 |
| Start Page: | 2847 |
| End Page: | 2848 |
| Language: | English |
| DOI: | 10.1182/blood.2020009408 |
| PROVIDER: | scopus |
| PUBMED: | 33331932 |
| PMCID: | PMC7751362 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 4 January 2021 -- Source: Scopus |
